SPONSOR
Jonsson Comprehensive Cancer Center
Total Trials
8
Recruiting
8
Phases
Phase 4, Phase 2, Phase 1, Phase 2, Phase 1
Conditions studied: ObesityMalignant NeoplasmBreast Cancer ScreeningArtificial Intelligence (AI)Recurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaDiffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma
Jonsson Comprehensive Cancer Center is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Obesity, Malignant Neoplasm, Breast Cancer Screening, Artificial Intelligence (AI).
The trial portfolio spans Phase 4, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jonsson Comprehensive Cancer Center
How many clinical trials has Jonsson Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Jonsson Comprehensive Cancer Center, of which 8 are actively recruiting participants. These trials cover conditions including Obesity, Malignant Neoplasm, Breast Cancer Screening. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jonsson Comprehensive Cancer Center research focus on?
Jonsson Comprehensive Cancer Center clinical trials span Obesity, Malignant Neoplasm, Breast Cancer Screening, Artificial Intelligence (AI), Recurrent Endometrial Carcinoma, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jonsson Comprehensive Cancer Center clinical trial?
To participate in a Jonsson Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jonsson Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Jonsson Comprehensive Cancer Center
NCT04453072
Recruiting
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
Obesity
NCT06934239 Phase 4
Recruiting
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Breast Cancer Screening
NCT04469764 Phase 2
Recruiting
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Recurrent Endometrial Carcinoma
NCT05256641 Phase 1, Phase 2
Recruiting
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma
NCT05775471 Phase 2
Recruiting
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
NCT03603223 Phase 2
Recruiting
Pembrolizumab in Treating Participants With Leukoplakia
Erythroleukoplakia
NCT07276438
Recruiting
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Localized Prostate Adenocarcinoma
NCT06650163 Phase 1
Recruiting
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
Glioma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology